Literature DB >> 15008247

Parathyroid surgical failures with misleading falls of intraoperative parathyroid hormone levels.

J Horányi1, L Duffek, R Szlávik, K Darvas, P Lakatos, M Tóth, K Rácz.   

Abstract

According to earlier reports, a decrease below 50% of baseline of intraoperative PTH levels measured 5 min after resection of the parathyroid adenoma predicts a cure of hyperparathyroidism. To reveal previously unrecognized pitfalls of intraoperative PTH measurements, we reviewed surgical failures in our series of parathyroidectomies combined with intraoperative PTH sampling. PTH measurements were performed in 251 patients with primary hyperparathyroidism (PHPT) between November 1999 and December 2002. PHPT due to parathyroid hyperplasia were found in 8 cases, double parathyroid adenomas in 6 cases, parathyroid carcinoma in 1 case and single parathyroid adenomas in 236 cases, all confirmed by histological examination. Of the 236 cases of single adenomas, initial surgery failed to cure PHPT in 4 patients. In 3 patients a false-positive decrease of intraoperative PTH (from 269 to 40 pg/ml, from 211 to 27 pg/ml, and from 140 to 59 pg/ml) was observed, whereas in the fourth patient a true-negative decrease of intraoperative PTH (from 758 to 401 pg/ml) was mistakenly interpreted as indication for a cure of PHPT. In each of the 4 patients in whom initial surgery failed the intervention included thyroid surgery and reoperative parathyroid surgery resulted in a permanent cure of PHPT. These observations support the possibility that thyroid surgery may compromise the blood supply of parathyroid adenomas resulting in a misleading drop of intraoperative PTH levels. Therefore, a careful evaluation of intraoperative PTH levels and, perhaps, other intraoperative aids such as histological evaluation of frozen sections are recommended when parathyroid surgery is combined with simultaneous thyroid intervention.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15008247     DOI: 10.1007/BF03345256

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  24 in total

1.  Intraoperative parathyroid hormone monitoring fails to detect double parathyroid adenomas: a 2-institution experience.

Authors:  P G Gauger; G Agarwal; B G England; L W Delbridge; K A Matz; M Wilkinson; B G Robinson; N W Thompson
Journal:  Surgery       Date:  2001-12       Impact factor: 3.982

2.  [New intraoperative diagnostic methods in parathyroid surgery: intraoperative measurement of parathyroid hormone].

Authors:  J Horányi; L Duffek; K Darvas; R Szlávik; K Pinkola; G Dabasi; C Horváth
Journal:  Orv Hetil       Date:  2001-06-24       Impact factor: 0.540

3.  Minimally invasive video-assisted parathyroidectomy: multiinstitutional study.

Authors:  K Lorenz; P Miccoli; J M Monchik; M Düren; H Dralle
Journal:  World J Surg       Date:  2001-06       Impact factor: 3.352

4.  Usefulness and limits of quick intraoperative measurements of intact (1-84) parathyroid hormone in the surgical management of hyperparathyroidism: sequential measurements in patients with multiglandular disease.

Authors:  C A Proye; A Goropoulos; C Franz; B Carnaille; M Vix; J L Quievreux; G Couplet-Lebon; A Racadot
Journal:  Surgery       Date:  1991-12       Impact factor: 3.982

5.  Minimal-access parathyroid surgery using intraoperative parathyroid hormone assay.

Authors:  R A Sofferman; J Standage; M E Tang
Journal:  Laryngoscope       Date:  1998-10       Impact factor: 3.325

6.  Video-assisted parathyroidectomy for primary hyperparathyroidism: a new approach involving a skin-lifting method.

Authors:  M Okido; S Shimizu; S Kuroki; K Yokohata; A Uchiyama; M Tanaka
Journal:  Surg Endosc       Date:  2001-10       Impact factor: 4.584

7.  Intraoperative parathormone level measurement in the management of hyperparathyroidism.

Authors:  C R McHenry; A Pollard; P G Walfish; I B Rosen
Journal:  Surgery       Date:  1990-10       Impact factor: 3.982

8.  Values of ultrasonography, sestamibi scintigraphy, and intraoperative measurement of 1-84 PTH for unilateral neck exploration of primary hyperparathyroidism.

Authors:  Y Chapuis; Y Fulla; P Bonnichon; E Tarla; B Abboud; J Pitre; B Richard
Journal:  World J Surg       Date:  1996-09       Impact factor: 3.352

9.  Advantages of combined technetium-99m-sestamibi scintigraphy and high-resolution ultrasonography in parathyroid localization: comparative study in 91 patients with primary hyperparathyroidism.

Authors:  F Lumachi; P Zucchetta; M C Marzola; P Boccagni; F Angelini; F Bui; D F D'Amico; G Favia
Journal:  Eur J Endocrinol       Date:  2000-12       Impact factor: 6.664

10.  Retrospective analysis of the association of nodular goiter with primary and secondary hyperparathyroidism.

Authors:  L dell'Erba; S Baldari; N Borsato; G Bruno; G Calò-Gabrieli; M Carletto; A Ciampolillo; M Dondi; P Erba; P Gerundini; S Lastoria; P Marinelli; M Santoro; B Scarano; P Zagni; M Bagnasco; G Mariani
Journal:  Eur J Endocrinol       Date:  2001-10       Impact factor: 6.664

View more
  4 in total

Review 1.  Best practice no 183. Examination of parathyroid gland specimens.

Authors:  S J Johnson; E A Sheffield; A M McNicol
Journal:  J Clin Pathol       Date:  2005-04       Impact factor: 3.411

2.  Intraoperative determination of PTH concentrations in fine needle tissue aspirates to identify parathyroid tissue during parathyroidectomy.

Authors:  János Horányi; László Duffek; Rezso Szlávik; István Takács; Miklós Tóth; László Romics
Journal:  World J Surg       Date:  2010-03       Impact factor: 3.352

3.  Risk factors for "PTH spikes" during surgery for primary hyperparathyroidism.

Authors:  Philipp Riss; Christoph Krall; Christian Scheuba; Christian Bieglmayer; Bruno Niederle
Journal:  Langenbecks Arch Surg       Date:  2013-07-05       Impact factor: 3.445

4.  Surgery for sporadic primary hyperparathyroidism: controversies and evidence-based approach.

Authors:  Antonio Sitges-Serra; Prieto Rosa; Mónica Valero; Estela Membrilla; Joan J Sancho
Journal:  Langenbecks Arch Surg       Date:  2008-02-21       Impact factor: 3.445

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.